CYP4F30P
Putative cytochrome P450 family member 4F30
Also known as: C4F30_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for CYP4F30P in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
118 residues, UniProt reviewed canonical sequence.
>Q9H0H9|CYP4F30P
1 MVTPAGCLGG RNQGPREIPG TAFPCSSRAG QTGQAVSGAQ VSSWRERQPF GGSRGPLHIL
61 GTDGNVDTTG KLGLVPTPPR IQKETKQGAL CGMKPPFLPE ALLTVWWLPF VAVSLCLFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP4F30P can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.71
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP4F30P as an antibody target. Whether an autoantibody or antibody against CYP4F30P could matter depends on whether native CYP4F30P is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP4F30P is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP4F30P as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...